Registration

PRIME POLICY GROUP for FERRING PHARMACEUTICALS INC.

Firm
Client
Income
—
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Access to in vitro fertilization therapeutics and procedures.

LobbyistCovered position, as disclosed
MARK DISLER New —
EMILY AUSTEN KATZ New 2013-15: Senior Health Policy Advisor, Sen. Barbara Boxer; 2010-13: Health Policy Director, Rep. Diana DeGette; 2009-10: Legislative Assistant, Sen. Ron Wyden; 2005-07: Legislative Aide, Sen. Ron Wyden; 2004: Biomedical Ethics Intern (Paid), NIH
RICH MEADE New 1997-2003: Chief of Staff, Rep. Jim Nussle; 2001-05: Chief of Staff, Committee on the Budget, House of Representatives
AQUILA POWELL New 1996-1999: Legislative Aide, US Senator Herb Kohl (D-WI); 1994-1995: Legislative Correspondent, Rep. John Bryant (D-TX); 1999-2001: Special Assistant, Office of the Assistant Secretary for Legislation
MITCHELL VAKERICS New 2007-08: Staff Assistant, Rep. Timothy Murphy; 2008-09: Legislative Correspondent/Press Assistant, Rep. Timothy Murphy; 2011-15: Legislative Counsel, Rep. Renee Ellmers; 2015: Legislative Director, Rep. Renee Ellmers

Foreign entities

Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.

EntityCountryPrincipal place of businessOwnershipContribution declared
FERRING INTERNATIONAL CENTER S.A. Switzerland Switzerland 100.0% —

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.